Shionogi Receives Contract with U.S. Government Through BARDA's Project BioShield to Enhance National Preparedness for Drug-Resistant Bacterial Threats Program Includes Establishing Pharmaceutical ...
In today's Pharmaceutical Executive Daily, Shionogi receives a contract worth up to $482 million to bolster U.S. preparedness against drug-resistant bacterial threats, Roche and C4 Therapeutics expand ...
Rep. Tom Davis (R-Va.), chairman of the House Government Reform Committee, requested information Dec. 5 from Michael Leavitt, secretary of the Department of Health and Human Services, regarding ...
DALLAS, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Spectral MD, Inc. (“SMD”), a subsidiary of Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI” or the “Company ...
Federal public health officials said Thursday that they anticipate Congress will soon pass the Project Bioshield legislation, a sweeping bill designed to strengthen the nation's biological defenses ...
Please join the CSIS Bipartisan Alliance for Global Health Security on Thursday, July 11 from 5:00 to 6:00 PM ET for a broadcast roundtable discussion on the occasion of the 20th anniversary of ...
IT IS EXCEEDINGLY rare these days to find something that the House and the Senate, the Republicans and the Democrats, can all agree on. But after the Senate's final passage of the Project Bioshield ...
OSAKA, Japan, April 08, 2026--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi ...
The MarketWatch News Department was not involved in the creation of this content. Program Includes Establishing Pharmaceutical Manufacturing in the U.S., Procurement and Development of Treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results